How to work together between nuclear medicine and radiotherapy departments?


Journal

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
ISSN: 1769-6658
Titre abrégé: Cancer Radiother
Pays: France
ID NLM: 9711272

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 22 01 2020
revised: 18 02 2020
accepted: 20 02 2020
pubmed: 13 4 2020
medline: 23 7 2020
entrez: 13 4 2020
Statut: ppublish

Résumé

Among the available imaging techniques, functional imaging provided by nuclear medicine departments represents a tool of choice for the oncoradiotherapist for targeting tumour activity, with positron emission tomography as the main modality. Before, during or after radiotherapy, functional imaging helps guide the oncoradiotherapist in making decisions and in the strategic choice of pathology management. Setting up a working group to ensure perfect coordination at all levels is the first step. Key points for a common and coordinated management between the two departments are the definition of an organizational logistic, training of personnel at every levels, standardization of nomenclatures, the choice of adapted and common equipment, implementation of regulatory controls, and research/clinical routine continuum. The availability of functional examinations dedicated to radiotherapy in clinical routine is possible and requires a convergence of teams and a pooling of tools and techniques.

Identifiants

pubmed: 32278652
pii: S1278-3218(20)30075-5
doi: 10.1016/j.canrad.2020.02.011
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

358-361

Informations de copyright

Copyright © 2020 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.

Auteurs

R Modzelewski (R)

Department of Nuclear Medicine, centre Henri-Becquerel, 1, rue d'Amiens, 76038 Rouen, France; CNRS, EA4108-Litis, FR UMR 3638, laboratoire QuantIF, 1, rue d'Amiens, 76000 Rouen, France. Electronic address: romain.modzelewski@chb.unicancer.fr.

D Gensanne (D)

CNRS, EA4108-Litis, FR UMR 3638, laboratoire QuantIF, 1, rue d'Amiens, 76000 Rouen, France; Department of Radiation Oncology, centre Henri-Becquerel, 1, rue d'Amiens, 76038 Rouen, France.

S Hapdey (S)

Department of Nuclear Medicine, centre Henri-Becquerel, 1, rue d'Amiens, 76038 Rouen, France; CNRS, EA4108-Litis, FR UMR 3638, laboratoire QuantIF, 1, rue d'Amiens, 76000 Rouen, France.

P Gouel (P)

Department of Nuclear Medicine, centre Henri-Becquerel, 1, rue d'Amiens, 76038 Rouen, France; CNRS, EA4108-Litis, FR UMR 3638, laboratoire QuantIF, 1, rue d'Amiens, 76000 Rouen, France.

P Vera (P)

Department of Nuclear Medicine, centre Henri-Becquerel, 1, rue d'Amiens, 76038 Rouen, France; CNRS, EA4108-Litis, FR UMR 3638, laboratoire QuantIF, 1, rue d'Amiens, 76000 Rouen, France.

S Thureau (S)

CNRS, EA4108-Litis, FR UMR 3638, laboratoire QuantIF, 1, rue d'Amiens, 76000 Rouen, France; Department of Radiation Oncology, centre Henri-Becquerel, 1, rue d'Amiens, 76038 Rouen, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH